Our investigation aims to unravel potential associations with other non-BC or non-OC tumour types with pathogenic or likely pathogenic mutations (hereinafter, PVs) in the RAD50, RAD51C, RAD51D, and BRIP1 genes. The gene discussed is RAD51D; the disease is breast cancer.